Last reviewed · How we verify
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
The study evaluates the rate beta-cell function decline in newly diagnosed type 2 diabetic patients on two different treatment regimens: insulin and metformin versus glyburide, metformin and pioglitazone.
Details
| Lead sponsor | University of Texas Southwestern Medical Center |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 58 |
| Start date | 2003-11 |
| Completion | 2011-12 |
Conditions
- Type 2 Diabetes Mellitus
Interventions
- Metformin
- Insulin
- Metfomin
- Pioglitazone
- glyburide
Primary outcomes
- Beta-cell Function - C-peptide AUC (Area Under the Curve) — 72 months
C-peptide AUC during a 3-hours mixed meal challenge testing
Countries
United States